REV1

There are 3 papers on REV1 in aging research: 1 observational study in people, 2 in animals.

Gene

3 papers study it2 findings

HGNCNCBI GeneTaxon

See all 3 papers on REV1

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: National Institute of Environmental Health Sciences
  • Humans1
  • Animals1
  • Model organisms1

Effects

2

Cellular senescence

downin mice1

1 study
  1. REV1 prevents cellular senescence in Rev1/Xpc double mutant mice.

    “This was associated with replication stress, genomic breaks, DNA damage signaling, senescence, and apoptosis in bone marrow.”

    Animalsin Rev1/Xpc double mutant micebone marrow

    Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions

    Blood

More on Cellular senescence

Aplastic anemia

downin mice1

1 study
  1. REV1 prevents aplastic anemia in mice (deficient for Rev1 and Xpc).

    “The additional disruption of Xpc, essential for global-genome nucleotide excision repair (ggNER) of helix-distorting nucleotide lesions, resulted in the perinatal loss of hematopoietic stem cells, progressive loss of bone marrow, and fatal aplastic anemia between 3 and 4 months of age.”

    Animalsdeficient for Rev1 and Xpc

    Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions

    Blood

More on Aplastic anemia

Latest